Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Acurx Pharmaceuticals, Inc. See All Filings	D	2025-06-27 16:10:57 UTC
Amount To Be Raised $3,978,664 Associated Brokers / Dealers H.C. WAINWRIGHT & CO., LLC CIK Number 0001736243 Filed Document 0001104659-25-063623 Exclusions or Exemptions 506b Accepted Date 2025-06-27 16:10:57 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Acurx Pharmaceuticals, Inc. See All Filings	D	2025-05-20 15:32:14 UTC
Amount To Be Raised $12,000,000 Associated Brokers / Dealers N/A CIK Number 0001736243 Filed Document 0001736243-25-000003 Exclusions or Exemptions 506b Accepted Date 2025-05-20 15:32:14 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Acurx Pharmaceuticals, Inc. See All Filings	D	2025-03-20 21:13:41 UTC
Amount To Be Raised $3,376,350 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001736243 Filed Document 0001736243-25-000002 Exclusions or Exemptions 506b Accepted Date 2025-03-20 21:13:41 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Acurx Pharmaceuticals, Inc. See All Filings	D	2025-01-17 17:11:20 UTC
Amount To Be Raised $2,404,259 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001736243 Filed Document 0001736243-25-000001 Exclusions or Exemptions 506b Accepted Date 2025-01-17 17:11:20 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Acurx Pharmaceuticals, LLC See All Filings	D	2020-01-17 17:17:04 UTC
Amount To Be Raised $6,000,000 Associated Brokers / Dealers N/A CIK Number 0001736243 Filed Document 0001736243-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-01-17 17:17:04 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Acurx Pharmaceuticals, LLC See All Filings	D/A	2019-10-30 13:39:24 UTC
Amount To Be Raised $7,842,500 Associated Brokers / Dealers N/A CIK Number 0001736243 Filed Document 0001736243-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-10-30 13:39:24 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Acurx Pharmaceuticals, LLC See All Filings	D/A	2018-10-30 13:07:18 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers N/A CIK Number 0001736243 Filed Document 0001736243-18-000004 Exclusions or Exemptions 506b Accepted Date 2018-10-30 13:07:18 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Acurx Pharmaceuticals, LLC See All Filings	D/A	2018-05-31 15:13:05 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers N/A CIK Number 0001736243 Filed Document 0001736243-18-000003 Exclusions or Exemptions 506b Accepted Date 2018-05-31 15:13:05 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Acurx Pharmaceuticals, LLC See All Filings	D	2018-04-03 10:10:16 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers N/A CIK Number 0001736243 Filed Document 0001736243-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-04-03 10:10:16 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity